Thus far 2025 has come roaring in as far as large rounds go. Last week more than a dozen companies raised $100 million or ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

US health systems and Regeneron Genetics Center launch the Truveta Genome Project, a $320M initiative to sequence up to 10M ...

Illumina’s Q4 revenue in 2024 was up 1% from the same period in 2023, totalling $1.1bn. Despite the positive end to the year, ...

The health systems, Illumina, and Regeneron have invested $320M in what Truveta calls the largest and most diverse database ...

Umoja Biopharma announced a $100 million Series C round that will help the Seattle-based company further develop its CAR ...

Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

The health data company, based in Bellevue, Washington, plans to collect leftover specimens from consenting patients who get routine health care at participating facilities, Stat reported. Also in the ...

Health data company Truveta is partnering with health systems and drugmakers to create a massive database of genetic data ...

The health care tech company launched just five years ago but is now valued at more than $1 billion after its latest funding ...

The Truveta Genome Project aims to establish the world’s largest and most diverse database of genetic information.